GSK3B and Alzheimer disease: Numerous studies have linked Wnt downregulation to cognitive dysfunctions in AD (Palomer et al. 2019; Jia et al. 2019), supporting the negative correlation between inactive GSK3β levels and AD-PRS observed in this study.